Portal:Nanomaterials/News
From WikiPathways
(Difference between revisions)
Current revision (16:13, 6 March 2023) (view source) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | * '''2017-03-24''' - The | + | * '''2023-03-06''' - AOP pathway for graphene oxide added ([[Pathway:WP5336]]) |
| + | * '''2021-04-12''' - Daphnia is a model system used to explore effects of nanomaterials. A [[Portal:Daphnia]] was started. | ||
| + | * '''2018-04-05''' - The list of [[Portal:Nanomaterials/FeaturedPathways|featured pathways]] is now a matrix with images. | ||
| + | * '''2017-03-24''' - The [http://enanomapper.net/ eNanoMapper] deliverable D4.4 describing the portal is now [https://zenodo.org/record/375613 archived at ZENODO]. | ||
* '''2016-08-31''' - A new pathway was added: "Nanomaterial induced inflammasome activation (Homo sapiens)" ([[Pathway:WP3890]]) | * '''2016-08-31''' - A new pathway was added: "Nanomaterial induced inflammasome activation (Homo sapiens)" ([[Pathway:WP3890]]) | ||
* '''2016-04-04''' - A new pathway was added: "Lung fibrosis (Homo sapiens)" ([[Pathway:WP3624]]) | * '''2016-04-04''' - A new pathway was added: "Lung fibrosis (Homo sapiens)" ([[Pathway:WP3624]]) | ||
Current revision
- 2023-03-06 - AOP pathway for graphene oxide added (Pathway:WP5336)
- 2021-04-12 - Daphnia is a model system used to explore effects of nanomaterials. A Portal:Daphnia was started.
- 2018-04-05 - The list of featured pathways is now a matrix with images.
- 2017-03-24 - The eNanoMapper deliverable D4.4 describing the portal is now archived at ZENODO.
- 2016-08-31 - A new pathway was added: "Nanomaterial induced inflammasome activation (Homo sapiens)" (Pathway:WP3890)
- 2016-04-04 - A new pathway was added: "Lung fibrosis (Homo sapiens)" (Pathway:WP3624)
- 2015-07-17 - A new pathway was added: "Overview of nanoparticle effects" (Pathway:WP3287)
- 2014-04-04 - A new pathway was added: "Nanoparticle-mediated activation of receptor signaling" (Pathway:WP2643)
- 2014-02-19 - This portal is a currently in alpha mode, meaning that it is a draft of what it will look like, and now exists to recruit two or three editors.
